www.ReProTect.eu   The Official ReProTect Website


  • Modeling Placental Transport: Correlation of In Vitro BeWo Cell Permeability and Ex Vivo Human Placental Perfusion
    Poulsenet al. (2009), Tox In Vitro 23, 1380-1386.
  • A review of the implementation of the embryonic stem cell test (EST). The report and recommendations of an ECVAM_ReProTect Workshop.
    Marx-Stoelting et al. (2009), Altern Lab Anim 37, 313-28
  • Development of an in vitro test battery for assessing chemical effects on bovine germ cells under the ReProTect umbrella
    Lazzari et al., (2008) Toxicology and Applied Pharmacology 233, 360-370
  • Embryotoxicity hazard assessment of cadmium and arsenic compounds using embryonic stem cells
    Stummann et al. (2008), Toxicology, 252, 118-122
  • The role of toxicology to characterize biomarkers for agrochemicals with potential endocrine activities
    Mantovani et al., (2008) Reprod Toxicol. 26, 1-7
  • Effects of some endocrine disruptors on the proliferation and viability of human endometrial endothelial cells in vitro
    Bredhult et al., (2007). Reprod Toxicol.23, 550-9
  • Screening of endocrine disrupting chemicals with MELN cells, an ER-transactivation assay combined with cytotoxicity assessment
    Berckmans et al., (2007) Toxicology in vitro 21, 1262-1267
  • The development of new concepts for assessing reproductive toxicity applicable to large scale toxicological programmes
    Bremer et al., (2007) Current Pharmaceutical design 13, 3047-3058
  • ReProComet: A New In Vitro Method to Assess DNA Damage in Mammalian Sperm
    Corderlli E. et al., (2007) Toxicological Sciences 99, 545-552
  • In Vitro Tests for Detecting Chemicals Affecting the Embryo Implantation Process
    Bremer et al., ATLA, Volume 35, 2007, pages 431 - 439
  • Structure-based modelling in reproductive toxicology: (Q)SARs for the placental barrier
    M. Hewitt; J. C. Madden; P. H. Rowe; M. T. D. Cronin
    SAR and QSAR in Environmental Research, Volume 18, Issue 1 & 2 January 2007, pages 57 - 76
  • Assessing Applicability Domains of Toxicological QSARs: Definition, Confidence in Predicted Values, and the Role of Mechanisms of Action
    Terry W. Schultz, Mark Hewitt, Tatiana I. Netzeva, Mark T. D. Cronin
    QSAR & Combinatorial Science, Volume 26, Issue 2, February 2007, pages 238 - 254
  • Risk assessment of endocrine disrupters
    Mantovani (2006), Ann. N.Y. Acad.Sci 1076, 239-252
  • Estrogen-Like Response to p-Nonylphenol in Human First Trimester
    Bechi et al., (2006) Tox. Scien., 1-7
  • Placental Perfusinon - A Human Alternative
    Mose and Knudsen (2006), ALTEX , 23, 358-363
  • Comparison of In Vitro and In Vivo Screening Models for Androgenic and Estrogenic Activities
    Sonneveld et al. (2006), Tox. Scien., 89, 173-187
  • 34th Annual Conference of the European Teratology Society
    Abstract, (2006), 22, 263-268
  • Vita da cavie
    A. Morresi, (2006) 18
  • Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and BPK modeling
    Verwei M. et al. (2006)
  • Development of Androgen- and Estrogen-Responsive Bioassays, Members of a Panel of Human Cell Line-Based Highly Selective Steroid-Responsive Bioassays
    Sonneveld et al., (2005) Tox Scien, 83, 136-148
  • The integrated project ReProTect: A novel approach in reproductive toxicity hazard assessment.
    Hareng L. et al., (2005) Rep. Tox. 20, 441-52
  • The Effects of Chemicals on Mammalian Fertility
    Bremer S. et al., (2005) ATLA 33, 391-416
  • Risk assessment of chemicals potentially affecting male fertility
    Mantovani A. et al., (2005) Contraception 72, 308-313
  • Long term effects of lonidamine on mouse testes
    Maranghi F. et al.,(2005) Contraception 72, 268-272
  • Neurotoxicity of active compounds. Establishment of hESC lines and proteomics technologies for human embryo and neurotoxicity screening and biomarker identification
    Klemme M. and Schrattenholz A. (2004) ALTEX 21, 41-48
  • A Modular Approach to the ECVAM Principles on Test Validity
    Hartung T. et al., (2004) ATLA 32, 467-472
© 2006 ReProTect. All Rights Reserved.